DiaMedCare

Founded 2016
Founders Gerhard Ries

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 1
Rounds per year 0.20
Lead investments 1
Key employees 3
Stages of investment
Late Stage Venture

Areas of investment

  • Artificial Intelligence
  • Software
  • Supply Chain Management
  • Logistics
  • Enterprise Software
Summary

In 2016 was created DiaMedCare, which is appeared as VC.

The important activity for fund was in 2019. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars.

The usual cause for the fund is to invest in rounds with 1 partaker. Despite the DiaMedCare, startups are often financed by Die Mobiliar, UBS, Credit Suisse. In the next rounds fund is usually obtained by Technology Fund.

This organization was formed by Gerhard Ries.

We can highlight the next thriving fund investment areas, such as Enterprise Software, Information Technology. Among the most popular portfolio startups of the fund, we may highlight Nexxiot. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of DiaMedCare:
Typical Co-investors
DiaMedCare is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after DiaMedCare:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from Switzerland, Basel
Funds with similar focus located in Switzerland, Basel:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
PremjiInvest India, Bangalore
Elephant United States, Boston
2nd Time Around United States, Boston
BMS Finance -
Palisades Growth Capital United States, Los Angeles
Cystic Fibrosis Foundation United States, Bethesda
CUNA Mutual Group United States, Madison
L-EigenkapitalAgentur Germany, Karlsruhe
Stark Capital Management,LLC United States, Houston
Macanta Investments -
French Investment Fund -
Perry Creek Capital United States, New York
Pathway Capital Management United States, Irvine
Yichang Boyue Investment Management China, Yichang
TrustBIX Canada, Edmonton
AUC Venture Lab Egypt, Cairo
Beijing Qianxiang Yixin Technology Development China, Beijing
Qianhai Huarui Tianfu China, Guangdong
TiPS China, Beijing
The Found Group United States, Los Angeles
L-EigenkapitalAgentur -

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Nexxiot

Artificial Intelligence
Enterprise Software
Information Technology
Internet of Things
Logistics
Software
Supply Chain Management
1
$38M31 May 2019 Switzerland, Zurich

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent DiaMedCare?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: